PubMed

A review of the economic burden of ADHD.

Matza LS, Paramore C, Prasad M.

Cost Eff Resour Alloc. 2005 Jun 9;3:5.PMID: 15946385 [PubMed]Related articlesFree article

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.

Insinga RP, Dasbach EJ, Elbasha EH.

Pharmacoeconomics. 2005;23(11):1107-22. Review.PMID: 16277547 [PubMed - indexed for MEDLINE]Related articles

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.PMID: 17874862 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK.

Prasad S, Arellano J, Steer C, Libretto SE.

Int J Clin Pract. 2009 Jul;63(7):1031-40.PMID: 19570121 [PubMed - in process]Related articles

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.PMID: 16796929 [PubMed - indexed for MEDLINE]Related articlesFree article

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ.

Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. Review.PMID: 19726018 [PubMed - indexed for MEDLINE]Related articlesFree article

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR.

Curr Med Res Opin. 2005 Feb;21(2):195-206.PMID: 15801990 [PubMed - indexed for MEDLINE]Related articles

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain.

Hong J, Dilla T, Arellano J.

BMC Psychiatry. 2009 Apr 14;9:15.PMID: 19366449 [PubMed - indexed for MEDLINE]Related articlesFree article

The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.

Pelham WE, Foster EM, Robb JA.

Ambul Pediatr. 2007 Jan-Feb;7(1 Suppl):121-31. Review.PMID: 17261491 [PubMed - indexed for MEDLINE]Related articles

The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.

Calvert NW, Burch SP, Fu AZ, Reeves P, Thompson TR.

J Manag Care Pharm. 2006 May;12(4):322-30.PMID: 16792438 [PubMed - indexed for MEDLINE]Related articlesFree article

The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.

Pelham WE, Foster EM, Robb JA.

J Pediatr Psychol. 2007 Jul;32(6):711-27. Epub 2007 Jun 7. Review.PMID: 17556402 [PubMed - indexed for MEDLINE]Related articles

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.

McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.

Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. Review.PMID: 17651658 [PubMed - indexed for MEDLINE]Related articlesFree article

Economic burden of haematological adverse effects in cancer patients: a systematic review.

Liou SY, Stephens JM, Carpiuc KT, Feng W, Botteman MF, Hay JW.

Clin Drug Investig. 2007;27(6):381-96. Review.PMID: 17506589 [PubMed - indexed for MEDLINE]Related articles

A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom.

Cottrell S, Tilden D, Robinson P, Bae J, Arellano J, Edgell E, Aristides M, Boye KS.

Value Health. 2008 May-Jun;11(3):376-88.PMID: 18489664 [PubMed - indexed for MEDLINE]Related articles

Antiviral agents for influenza: a comparison of cost-effectiveness data.

Lynd LD, Goeree R, O'Brien BJ.

Pharmacoeconomics. 2005;23(11):1083-106. Review.PMID: 16277546 [PubMed - indexed for MEDLINE]Related articles

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.PMID: 19445548 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.

Botteman MF, Ozminkowski RJ, Wang S, Pashos CL, Schaefer K, Foley DJ.

CNS Drugs. 2007;21(4):319-34. Erratum in: CNS Drugs. 2006;21(5):405. PMID: 17381185 [PubMed - indexed for MEDLINE]Related articles

The economic burden of allergic rhinitis: a critical evaluation of the literature.

Reed SD, Lee TA, McCrory DC.

Pharmacoeconomics. 2004;22(6):345-61. Review.PMID: 15099121 [PubMed - indexed for MEDLINE]Related articles

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French. PMID: 15959450 [PubMed - indexed for MEDLINE]Related articles